HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Japanese multiple epidermal growth factor 10 (MEGF10) myopathy with novel mutations: A phenotype-genotype correlation.

Abstract
Mutations in the multiple epidermal growth factor-like domains 10 (MEGF10: NM_032446.2) gene are known to cause early-onset myopathy characterized by areflexia, respiratory distress, and dysphagia (EMARDD: OMIM 614399), and a milder phenotype of minicore myopathy. To date, there have been reports of six families with EMARDD and one with a milder disorder. Cysteine mutations in the extracellular EGF-like domain may be responsible for the milder phenotype, but the relationship is not conclusive because of the few reports of this disorder. We here present two Japanese patients with MEGF10 mutations: one with EMARDD phenotype who had a novel homozygous frameshift mutation, c.131_132del, and the other with the milder phenotype who harbored a compound heterozygous mutation, c.2981-2A > G, and a novel missense mutation, p.Cys810Tyr. This is the first report on East Asian patients with MEGF10 myopathy showing two phenotypes, indicating the genotype-phenotype correlation in MEGF10 myopathy.
AuthorsKazuko Takayama, Satomi Mitsuhashi, Je-Young Shin, Rieko Tanaka, Tatsuya Fujii, Rie Tsuburaya, Souichi Mukaida, Satoru Noguchi, Ikuya Nonaka, Ichizo Nishino
JournalNeuromuscular disorders : NMD (Neuromuscul Disord) Vol. 26 Issue 9 Pg. 604-9 (09 2016) ISSN: 1873-2364 [Electronic] England
PMID27460346 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • MEGF10, human
  • Membrane Proteins
Topics
  • Adolescent
  • Fatal Outcome
  • Female
  • Genetic Association Studies
  • Humans
  • Male
  • Membrane Proteins (genetics)
  • Muscular Diseases (genetics, pathology, physiopathology)
  • Mutation
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: